23 AUDITOR’S REMUNERATION For the year ended 30 June 2025 $ For the year ended 30 June 2024 $ Amounts received or due and receivable by the Company’s auditors Grant Thornton for: - Auditing the statutory financial report of the Parent company of the Group and auditing the statutory financial reports of any controlled entity. 123,375 118,965 123,375 118,965 24 RELATED PARTY DISCLOSURES Other related party transactions (A) WHOLLY OWNED GROUP TRANSACTIONS Details of interests in controlled entities are set out in Note 25. (B) ULTIMATE PARENT COMPANY INOVIQ Limited is the ultimate legal Australian holding Company. (C) TRANSACTIONS WITH OTHER RELATED PARTIES Kidder Williams, a Corporate Advisory and Investment Banking services firm owned by INOVIQ Chairman David Williams, received Corporate Advisory fees from INOVIQ during the year totalling $10,000. Kidder Williams also advised INOVIQ on its 2024 capital raise, receiving $65,080 for services provided in conjunction with the SPP and director placement component of the raising. The Company does not have any other transactions with other related parties. 25 CONTROLLED ENTITIES Consolidated entities of INOVIQ Ltd Country of Incorporation Equity Interest held % 30 June 2025 30 June 2024 Sienna Cancer Diagnostics Limited Australia 100 100 INOVIQ Inc. (formerly Sienna Cancer Diagnostics Inc.) U.S.A. 100 100 Melbourne Diagnostics Pty Ltd Australia 100 100 26 EVENTS SUBSEQUENT TO BALANCE DATE At the date of this report, there have been no matters or circumstances that have arisen since the end of the period which significantly, or may significantly affect: – The Group’s operations in future years; – The results of those operations in future years; or – The Group’s state of affairs in future years. Notes to the Financial Statements continued for the year ended 30 June 2025 56 INOVIQ Limited
RkJQdWJsaXNoZXIy MjE2NDg3